Candel Therapeutics (CADL) Q4 2024 Earnings

Nov 14Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.74
-0.49
-0.25
0

Details

Expected EPS
N/A
Actual EPS
-0.33
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Candel Therapeutics⁩ (⁦CADL⁩) has reported earnings of ⁦-0.33⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts